952-285-8000
abwhc@comcast.net

6600 France Avenue South Suite 600,
Edina, MN 55435

GLP-1 receptor antagonists medication

It looks like there might be a slight mix-up in the terminology. Based on current medical literature and FDA-approved treatments, there are no medications classified as "GLP-1 receptor antagonists." All the well-known drugs in this category are GLP-1 receptor agonists, which mimic the natural hormone to produce their effects .

The term "antagonist" is not accurate for approved drugs, though the search results indicate it is being explored in novel, next-generation therapies . The table below outlines the GLP-1 agonist medications currently available.

Overview of GLP-1 Receptor Agonist Medications

The table below summarizes the primary GLP-1 and related multi-agonist drugs available, based on information from the MSD Manuals and other clinical sources .

  • Class Examples (Brand Names) Administration FDA-Approved Indications
  • GLP-1 Receptor Agonists Semaglutide (Ozempic®, Wegovy®, Rybelsus®), Liraglutide (Victoza®, Saxenda®), Dulaglutide (Trulicity®), Exenatide (Byetta®, Bydureon®) Subcutaneous injection (weekly or daily); Semaglutide also available as a daily oral tablet (Rybelsus®) Type 2 diabetes (T2DM), chronic weight management, and reduction of major cardiovascular events in high-risk patients
  • Dual GIP/GLP-1 Receptor Agonists Tirzepatide (Mounjaro®, Zepbound®) Subcutaneous injection (weekly) T2DM (Mounjaro®), chronic weight management and obstructive sleep apnea (Zepbound®)

Understanding How They Work and What to Expect

  • Mechanism of Action: These drugs work by mimicking the natural incretin hormone GLP-1. This slows digestion, increases feelings of fullness (satiety), and enhances insulin secretion when blood sugar is high, leading to improved glycemic control and weight loss .
  • Key Effects: Clinical trials show significant results. Tirzepatide has demonstrated approximately 16% weight reduction after 12-18 months, while semaglutide shows about 11% weight loss over a similar period. These medications are also associated with improved cardiovascular outcomes .
  • Common Side Effects: The most frequent adverse effects are gastrointestinal issues like nausea, vomiting, diarrhea, and constipation. These are often mild-to-moderate and can be minimized by slowly increasing the dose . More serious risks, though rare, include potential for acute pancreatitis and, based on animal studies, thyroid C-cell tumors .
  • A Note on "Antagonists": The search results show that while no GLP-1 antagonists are currently approved, research into next-generation drugs is exploring this concept. For example, a drug called "maridebart cafraglutide" combines GLP-1 agonism with GIP receptor antagonism as an experimental approach . This is distinct from the standard GLP-1 drugs available today.

Important Considerations

It is crucial to remember that all GLP-1 receptor agonist medications are prescription-only. They are not suitable for everyone—for instance, they are contraindicated for individuals with a personal or family history of medullary thyroid carcinoma .

A healthcare professional can help determine if a GLP-1 receptor agonist is appropriate for you, considering your specific health history, treatment goals, and insurance coverage .
Contact us
Contact
952-285-8000
abwhc@comcast.net
Address
A Better Way Health Center
6600 France Avenue South, Suite 600
Edina, MN 55435
Appointment Hours:
Monday: 8 am to 8 pm
Tuesday: 8 am to 8 pm
Wednesday: 8 am to 4 pm
Thursday: Closed
Friday: Closed
Saturday: 7:30 am to 1 pm
Sunday: Closed
Please call
for appointment
Phone
Quick Links
Contact Info
  • 952-285-8000
  • abwhc@comcast.net
  • 6600 France Ave S, Suite 600, Edina, MN 55435